Affimed Shares Fall 32 percent on Clinical Update
AFMD Stock | USD 1.51 0.62 29.11% |
About 63% of Affimed NV's investor base is looking to short. The analysis of the overall investor sentiment regarding Affimed NV suggests that many traders are alarmed. The current market sentiment, together with Affimed NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Affimed NV stock news signals to limit their universe of possible portfolio assets.
Affimed |
After disclosing revised clinical results for its AFM24atezolizumab combination treatment in non-small cell lung cancer, Affimed N.V. shares
Read at gurufocus.com
Affimed NV Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Affimed NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Affimed NV Fundamental Analysis
We analyze Affimed NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affimed NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affimed NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Affimed NV is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Affimed NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Affimed NV stock to make a market-neutral strategy. Peer analysis of Affimed NV could also be used in its relative valuation, which is a method of valuing Affimed NV by comparing valuation metrics with similar companies.
Peers
Affimed NV Related Equities
HEPA | Hepion Pharmaceuticals | 7.36 | ||||
CRVS | Corvus Pharmaceuticals | 7.10 | ||||
APTO | Aptose Biosciences | 5.56 | ||||
AGEN | Agenus | 4.59 | ||||
ADAP | Adaptimmune Therapeutics | 1.69 | ||||
PDSB | PDS Biotechnology | 0.51 | ||||
DAWN | Day One | 0.87 | ||||
ELEV | Elevation Oncology | 1.73 | ||||
LPTX | Leap Therapeutics | 1.93 | ||||
MREO | Mereo BioPharma | 2.65 | ||||
INZY | Inozyme Pharma | 6.12 | ||||
ADCT | ADC Therapeutics | 10.33 | ||||
XFOR | X4 Pharmaceuticals | 13.36 | ||||
TERN | Terns Pharmaceuticals | 15.29 | ||||
PIRS | Pieris Pharmaceuticals | 15.69 |
Complementary Tools for Affimed Stock analysis
When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |